Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel disease

Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel disease

US Patent 12139484 · Granted Nov 12, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MEK inhibitors and uses thereof2025
Compounds and uses thereof2025
Compounds and uses thereof2025
Compounds and uses thereof2025
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024
MEK inhibitors and uses thereof2024
Pyruvate kinase modulators and use thereof2024
Compounds and uses thereof2023
BRD9 degraders and uses thereof2023
Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, an2023
Methods and compounds for treating disorders2023